Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: A systematic review and meta-analysis

Neuroendocrinology

Volumn 101, Issue 2, 2015, Pages 133-142

  Haugvik, Sven Petter ^a,b   Hedenström, Per ^c   Korsæth, Emilie ^b   Valente, Roberto ^d   Hayes, Alastair ^f   Siuka, Darko ^g   Maisonneuve, Patrick ^e   Gladhaug, Ivar Prydz ^a,b   Lindkvist, Björn ^c   Capurso, Gabriele ^d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Epidemiology; Meta analysis; Neuroendocrine tumor; Pancreatic neuroendocrine tumor; Risk factor; Sporadic pancreatic neuroendocrine tumor

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER RISK; DIABETES MELLITUS; FAMILY HISTORY; HUMAN; MEDICAL RECORD; META ANALYSIS (TOPIC); PANCREATIC NEUROENDOCRINE TUMOR; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SMOKING; SYSTEMATIC REVIEW; TELEPHONE INTERVIEW; DRINKING BEHAVIOR; EUROPE; META ANALYSIS; NEUROENDOCRINE TUMORS; NORTH AMERICA; PANCREATIC NEOPLASMS; RISK FACTOR;

ALCOHOL DRINKING; DIABETES MELLITUS; EUROPE; HUMANS; NEUROENDOCRINE TUMORS; NORTH AMERICA; PANCREATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 84929964597     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000375164     Document Type: Article

References (21)

1. Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM: Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113: 2655-2664.
2. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB: One hundred years after 'carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072.
3. Fitzgerald TL, Hickner ZJ, Schmitz M, Kort EJ: Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas 2008; 37: 134-138.
4. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z: Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 2011; 47: 1928-1937.
5. Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, Bosetti C, Li D, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Bag hurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Gao YT, Negri E, Hassan M, Cotterchio M, Su J, Maisonneuve P, Boffetta P, Duell EJ: Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 2012; 23: 374-382.
6. Bosetti C, Lucenteforte E, Silverman DT, et al: Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 2012; 23: 1880-1888.
7. Jacobs EJ, Chanock SJ, Fuchs CS, et al: Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer 2010; 127: 1421-1428.
8. Capurso G, Falconi M, Panzuto F, Rinzivillo M, Boninsegna L, Bettini R, Corleto V, Borgia P, Pederzoli P, Scarpa A, Delle Fave G: Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. Am J Gastroenterol 2009; 104: 3034-3041.
9. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC: Risk factors associated with neuroendocrine tumors: a US-based casecontrol study. Int J Cancer 2008; 123: 867-873.
10. Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G: Risk factors for the occurrence of insulinoma: a case-control study. Hepatobiliary Pancreat Dis Int 2013; 12: 324-328.
11. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC: Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 959-965.
12. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
13. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
14. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
16. Egger M, Davey SG, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
17. Halfdanarson T, Bamlet W, McWilliams R, Hobday T, Burch P, Petersen G: Risk factors for sporadic pancreatic neuroendocrine tumors (PNETs): updated results from a singlecenter case control study. Neuroendocrinology 2012; 96: 34.
18. Halfdanarson TR, Bamlet WR, Hobday TJ, McWilliams RR, Petersen GM: Risk factors for sporadic pancreatic neuroendocrine tumors (PNETs): a single-center case control study. Pancreas 2010; 39: 273.
19. Cote ML, Schenk M, Schwartz AG, Vigneau FD, Kinnard M, Greenson JK, Fryzek JP, Ying GS, Garabrant DH: Risk of other cancers in individuals with a family history of pancreas cancer. J Gastrointest Cancer 2007; 38: 119-126.
20. Turati F, Negri E, La Vecchia C: Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther 2014; 14: 1-4.
21. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M: Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 2010; 45: 234-243.